Combination treatment of TACE [transcatheter arterial chemoembolisation] with recombinant human endosta[t]in administrated via hepatic artery in hepatocellular carcinoma.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Endostatin (Primary) ; Epirubicin; Ethiodized oil
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 30 Aug 2007 New trial record.